1. Home
  2. ACXP vs LSTA Comparison

ACXP vs LSTA Comparison

Compare ACXP & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACXP
  • LSTA
  • Stock Information
  • Founded
  • ACXP 2017
  • LSTA 1980
  • Country
  • ACXP United States
  • LSTA United States
  • Employees
  • ACXP N/A
  • LSTA N/A
  • Industry
  • ACXP Biotechnology: Pharmaceutical Preparations
  • LSTA Misc Health and Biotechnology Services
  • Sector
  • ACXP Health Care
  • LSTA Health Care
  • Exchange
  • ACXP Nasdaq
  • LSTA Nasdaq
  • Market Cap
  • ACXP 31.4M
  • LSTA 31.2M
  • IPO Year
  • ACXP 2021
  • LSTA N/A
  • Fundamental
  • Price
  • ACXP $0.74
  • LSTA $2.51
  • Analyst Decision
  • ACXP Strong Buy
  • LSTA Strong Buy
  • Analyst Count
  • ACXP 1
  • LSTA 1
  • Target Price
  • ACXP $12.00
  • LSTA $15.00
  • AVG Volume (30 Days)
  • ACXP 144.3K
  • LSTA 58.9K
  • Earning Date
  • ACXP 03-14-2025
  • LSTA 02-27-2025
  • Dividend Yield
  • ACXP N/A
  • LSTA N/A
  • EPS Growth
  • ACXP N/A
  • LSTA N/A
  • EPS
  • ACXP N/A
  • LSTA N/A
  • Revenue
  • ACXP N/A
  • LSTA N/A
  • Revenue This Year
  • ACXP N/A
  • LSTA N/A
  • Revenue Next Year
  • ACXP N/A
  • LSTA N/A
  • P/E Ratio
  • ACXP N/A
  • LSTA N/A
  • Revenue Growth
  • ACXP N/A
  • LSTA N/A
  • 52 Week Low
  • ACXP $0.68
  • LSTA $2.19
  • 52 Week High
  • ACXP $3.35
  • LSTA $4.20
  • Technical
  • Relative Strength Index (RSI)
  • ACXP 43.00
  • LSTA 40.33
  • Support Level
  • ACXP $0.73
  • LSTA $2.51
  • Resistance Level
  • ACXP $0.82
  • LSTA $2.66
  • Average True Range (ATR)
  • ACXP 0.05
  • LSTA 0.19
  • MACD
  • ACXP 0.01
  • LSTA -0.01
  • Stochastic Oscillator
  • ACXP 26.03
  • LSTA 17.50

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

Share on Social Networks: